Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Dinah Foer, M.D.


Yale School of Medicine, New Haven, CTMD05/2014
Brigham and Women's Hospital, Boston, MA06/2017Internal Medicine Residency
Brigham and Women's Hospital, Boston, MA06/2020Allergy and Immunology Fellowship

The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. K23HL161332 (Dinah Foer)
    Effects of GLP-1 Receptor Agonists on Airway Inflammation and Platelet Activation in Asthma

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Foer D, Wien M, Karlson EW, Song W, Boyce JA, Brennan PJ. Patient Characteristics Associated With Reactions to Mrgprx2-Activating Drugs in an Electronic Health Record-Linked Biobank. J Allergy Clin Immunol Pract. 2022 Nov 07. PMID: 36356925.
    Citations:    Fields:    
  2. Cahill KN, Amin T, Boutaud O, Printz R, Newcomb DC, Foer D, Hodson DJ, Broichhagen J, Beckman JA, Yu C, Nian H, Mashayekhi M, Silver HJ, Luther JM, Brown NJ, Peebles RS, Niswender K. Glucagon-Like Peptide-1 Receptor Regulates Thromboxane-Induced Human Platelet Activation. JACC Basic Transl Sci. 2022 Jul; 7(7):713-715. PMID: 35958685; PMCID: PMC9357570.
  3. Li Y, Dai R, Gwon Y, Rennard SI, Make BJ, Foer D, Strand MJ, Austin E, Young KA, Hokanson JE, Pratte KA, Conway R, Kinney GL. Identifying Individual Medications Affecting Pulmonary Outcomes When Multiple Medications are Present. Clin Epidemiol. 2022; 14:731-735. PMID: 35677475; PMCID: PMC9167843.
  4. Li L, Foer D, Hallisey RK, Hanson C, McKee AE, Zuccotti G, Mort EA, Sequist TD, Kaufman NE, Seguin CM, Kachalia A, Blumenthal KG, Wickner PG. Improving Allergy Documentation: A Retrospective Electronic Health Record System-Wide Patient Safety Initiative. J Patient Saf. 2022 01 01; 18(1):e108-e114. PMID: 32487880; PMCID: PMC7704710.
    Citations: 1     Fields:    Translation:Humans
  5. Syrowatka A, Song W, Amato MG, Foer D, Edrees H, Co Z, Kuznetsova M, Dulgarian S, Seger DL, Simona A, Bain PA, Purcell Jackson G, Rhee K, Bates DW. Key use cases for artificial intelligence to reduce the frequency of adverse drug events: a scoping review. Lancet Digit Health. 2022 02; 4(2):e137-e148. PMID: 34836823.
    Citations: 1     Fields:    Translation:Humans
  6. Wang L, Foer D, MacPhaul E, Lo YC, Bates DW, Zhou L. PASCLex: A comprehensive post-acute sequelae of COVID-19 (PASC) symptom lexicon derived from electronic health record clinical notes. J Biomed Inform. 2022 01; 125:103951. PMID: 34785382; PMCID: PMC8590503.
    Citations:    Fields:    Translation:HumansCells
  7. Arroyo AC, Sanchez DA, Camargo CA, Wickner PG, Foer D. Evaluation of Allergic Diseases in Transgender and Gender-Diverse Patients: A Case Study of Asthma. J Allergy Clin Immunol Pract. 2022 01; 10(1):352-354. PMID: 34782303; PMCID: PMC8748393.
    Citations:    Fields:    Translation:Humans
  8. Rudin RS, Perez S, Rodriguez JA, Sousa J, Plombon S, Arcia A, Foer D, Bates DW, Dalal AK. User-centered design of a scalable, electronic health record-integrated remote symptom monitoring intervention for patients with asthma and providers in primary care. J Am Med Inform Assoc. 2021 10 12; 28(11):2433-2444. PMID: 34406413; PMCID: PMC8510383.
    Citations: 2     Fields:    Translation:Humans
  9. Rudin RS, Qureshi N, Foer D, Dalal AK, Edelen MO. Toward an asthma patient-reported outcome measure for use in digital remote monitoring. J Asthma. 2022 08; 59(8):1697-1702. PMID: 34279179.
    Citations:    Fields:    Translation:Humans
  10. Foer D, Cahill KN. Comment on Albogami et al. Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344-1352. Diabetes Care. 2021 08; 44(8):e165-e166. PMID: 34285099.
    Citations:    Fields:    Translation:Humans
  11. Foer D, Beeler PE, Cui J, Karlson EW, Bates DW, Cahill KN. Asthma Exacerbations in Patients with Type 2 Diabetes and Asthma on Glucagon-like Peptide-1 Receptor Agonists. Am J Respir Crit Care Med. 2021 04 01; 203(7):831-840. PMID: 33052715; PMCID: PMC8017590.
    Citations: 13     Fields:    Translation:Humans
  12. Foer D, Beeler PE, Cui J, Karlson EW, Bates DW, Cahill KN. Reply to Watchorn et al.: Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes. Am J Respir Crit Care Med. 2021 04 01; 203(7):924-925. PMID: 33508207; PMCID: PMC8017586.
    Citations:    Fields:    Translation:Humans
  13. Baek SH, Foer D, Cahill KN, Israel E, Maiorino E, Röhl A, Boyce JA, Weiss ST. Systems Approaches to Treatment Response to Imatinib in Severe Asthma: A Pilot Study. J Pers Med. 2021 Mar 25; 11(4). PMID: 33805900.
  14. Foer D, Rubins D, Almazan A, Wickner PG, Bates DW, Hamnvik OR. Gender Reference Use in Spirometry for Transgender Patients. Ann Am Thorac Soc. 2021 03; 18(3):537-540. PMID: 33058733; PMCID: PMC7919147.
    Citations: 1     Fields:    Translation:Humans
  15. Giannetti MP, Weller E, Alvarez-Twose I, Torrado I, Bonadonna P, Zanotti R, Dwyer DF, Foer D, Akin C, Hartmann K, Rama TA, Sperr WR, Valent P, Teodosio C, Orfao A, Castells M. COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms. J Allergy Clin Immunol Pract. 2021 05; 9(5):2083-2086. PMID: 33631409.
    Citations: 5     Fields:    Translation:HumansCells
  16. Broyles AD, Banerji A, Barmettler S, Biggs CM, Blumenthal K, Brennan PJ, Breslow RG, Brockow K, Buchheit KM, Cahill KN, Cernadas J, Chiriac AM, Crestani E, Demoly P, Dewachter P, Dilley M, Farmer JR, Foer D, Fried AJ, Garon SL, Giannetti MP, Hepner DL, Hong DI, Hsu JT, Kothari PH, Kyin T, Lax T, Lee MJ, Lee-Sarwar K, Liu A, Logsdon S, Louisias M, MacGinnitie A, Maciag M, Minnicozzi S, Norton AE, Otani IM, Park M, Patil S, Phillips EJ, Picard M, Platt CD, Rachid R, Rodriguez T, Romano A, Stone CA, Torres MJ, Verdú M, Wang AL, Wickner P, Wolfson AR, Wong JT, Yee C, Zhou J, Castells M. Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs. J Allergy Clin Immunol Pract. 2020 10; 8(9S):S16-S116. PMID: 33039007.
    Citations: 28     Fields:    Translation:Humans
  17. Foer D, Tran LK, Wickner P, Castells M, Marquis KA, Buchheit KM. Challenges in skin testing for progestogen hypersensitivity. Ann Allergy Asthma Immunol. 2021 01; 126(1):100-102. PMID: 32911056.
    Citations:    Fields:    Translation:Humans
  18. Wang L, Foer D, Bates DW, Boyce JA, Zhou L. Risk factors for hospitalization, intensive care, and mortality among patients with asthma and COVID-19. J Allergy Clin Immunol. 2020 10; 146(4):808-812. PMID: 32735807; PMCID: PMC7387277.
    Citations: 20     Fields:    Translation:HumansCellsPHPublic Health
  19. Foer D, Rubins DM, Almazan A, Chan K, Bates DW, Hamnvik OR. Challenges with Accuracy of Gender Fields in Identifying Transgender Patients in Electronic Health Records. J Gen Intern Med. 2020 12; 35(12):3724-3725. PMID: 31808128.
    Citations: 4     Fields:    Translation:Humans
  20. Foer D, Marquis K, Romero N, Castells MC. Challenges and safety of beta-lactam desensitization during extracorporeal membrane oxygenation. Ann Allergy Asthma Immunol. 2019 06; 122(6):661-663. PMID: 30878628; PMCID: PMC6555662.
    Citations:    Fields:    Translation:Humans
  21. Foer D, Buchheit KM. Presentation and natural history of progestogen hypersensitivity. Ann Allergy Asthma Immunol. 2019 02; 122(2):156-159. PMID: 30712576; PMCID: PMC6497082.
    Citations:    Fields:    Translation:Humans
  22. Foer D, Buchheit KM. Progestogen Hypersensitivity: An Evidence-Based Approach to Diagnosis and Management in Clinical Practice. Immunol Allergy Clin North Am. 2017 11; 37(4):773-784. PMID: 28965640.
    Citations: 3     Fields:    Translation:Humans
  23. Foer D, Zhu M, Cardone RL, Simpson C, Sullivan R, Nemiroff S, Lee G, Kibbey RG, Petersen KF, Insogna KL. Impact of gain-of-function mutations in the low-density lipoprotein receptor-related protein 5 (LRP5) on glucose and lipid homeostasis. Osteoporos Int. 2017 06; 28(6):2011-2017. PMID: 28283687.
    Citations: 3     Fields:    Translation:HumansCells
  24. Foer D, Buchheit KM, Gargiulo AR, Lynch DM, Castells M, Wickner PG. Progestogen Hypersensitivity in 24 Cases: Diagnosis, Management, and Proposed Renaming and Classification. J Allergy Clin Immunol Pract. 2016 Jul-Aug; 4(4):723-9. PMID: 27090357.
    Citations: 21     Fields:    Translation:Humans
  25. Simpson CA, Foer D, Lee GS, Bihuniak J, Sun B, Sullivan R, Belsky J, Insogna KL. Serum levels of sclerostin, Dickkopf-1, and secreted frizzled-related protein-4 are not changed in individuals with high bone mass causing mutations in LRP5. Osteoporos Int. 2014 Oct; 25(10):2383-8. PMID: 24927689.
    Citations: 2     Fields:    Translation:HumansCells
  26. Lee GS, Simpson C, Sun BH, Yao C, Foer D, Sullivan B, Matthes S, Alenina N, Belsky J, Bader M, Insogna KL. Measurement of plasma, serum, and platelet serotonin in individuals with high bone mass and mutations in LRP5. J Bone Miner Res. 2014 Apr; 29(4):976-81. PMID: 24038240.
    Citations: 18     Fields:    Translation:Humans
  27. Foer D, Ornstein K, Soriano TA, Kathuria N, Dunn A. Nonmedical factors associated with prolonged hospital length of stay in an urban homebound population. J Hosp Med. 2012 Feb; 7(2):73-8. PMID: 22173979.
    Citations: 7     Fields:    Translation:Humans
  28. Ornstein K, Smith KL, Foer DH, Lopez-Cantor MT, Soriano T. To the hospital and back home again: a nurse practitioner-based transitional care program for hospitalized homebound people. J Am Geriatr Soc. 2011 Mar; 59(3):544-51. PMID: 21391944.
    Citations: 13     Fields:    Translation:Humans
  29. Fisher PG, Jenab J, Gopldthwaite PT, Tihan T, Wharam MD, Foer DR, Burger PC. Outcomes and failure patterns in childhood craniopharyngiomas. Childs Nerv Syst. 1998 Oct; 14(10):558-63. PMID: 9840379.
    Citations: 27     Fields:    Translation:HumansPHPublic Health
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Foer's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (117)
Co-Authors (49)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.